Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2007-4-18
pubmed:abstractText
Oncogene signaling is known to deregulate cell proliferation resulting in uncontrolled growth and cellular transformation. Gene amplification and/or somatic mutations of the HER2/Neu (ErbB2) proto-oncogene occur in approximately 20% of breast cancers. A therapeutic strategy that has been used to block HER2 function is the small molecule tyrosine kinase inhibitor lapatinib. Using human mammary epithelial cells that overexpress HER2, we determined the anti-proliferative effect of lapatinib through measuring the total cell number and analyzing the cell cycle distribution. A mathematical model was used to interpret the experimental data.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-10986055, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-11156523, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-11252954, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-11533657, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-11965249, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-12909255, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-1350088, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-14117037, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-15044465, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-15087399, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-15158434, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-15684311, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-16091755, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-16195878, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-16418322, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-16452222, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-16516246, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-16697424, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-16843263, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-16861913, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-16894399, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-1713661, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-2250141, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-2470152, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-4933846, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-7538656, http://linkedlifedata.com/resource/pubmed/commentcorrection/17407594-7819273
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1742-4682
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
14
pubmed:dateRevised
2010-9-15
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
relocating job wise? A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor.
pubmed:affiliation
Department of Mathematics, Vanderbilt University, Nashville, TN 37240, USA. peter.hinow@vanderbilt.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural